Star Combo Pharma Share Price and Company Fundamentals
Last traded: Yesterday at 11:14 PM
Star Combo Pharma Limited manufactures and distributes health food products and nutritional supplements in Australia and China. It operates in two segments, OEM and Retail. The company develops, manufactures, markets, and sells natural health supplements and skin care products. It also provides its products through e-commerce platform to Chinese health product consumers. The company sells its products under the Costar, Living Healthy, Amax, and J&K brands. Star Combo Pharma Limited was founded in 2004 and is based in Smithfield, Australia.
Key Metrics
PE ratio
6.00
PB ratio
0.85
Dividend yield
1.54%
Beta
0.45
Market cap
$32.42M
Enterprise value
$18.43M
Company profile
| Industry / Sector | Household & Personal Products / Consumer Defensive |
|---|---|
| Website | https://www.starcombo.com.au |
| Mailing address | 171-177 Woodpark Road Smithfield NSW 2164 Australia |
| Phone / Fax | 61 2 9756 6555 / 61 2 8798 3088 |
Dividends
More: Star Combo Pharma Dividend history, yield and payout ratio
Dividend yield
1.54%
Dividend amount
$0.00
Payout ratio
9.51%
5Y Avg. yield
-%
Star Combo Pharma paid $0.00 dividend and the ex-dividend date was 14 Oct 2025.The dividend payout ratio is 9.51%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.S66 dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Star Combo Pharma.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Ms. Su Zhang M.B.A. | CEO & Executive Director | ||
| Mr. JinXing Zhang B.S. | Founder, MD & Director | ||
| Mr. James Ni | Chief Financial Officer | ||
| He Ben B.S. | Chief Operating Officer | ||
| Mr. Patrick James Raper F.A.C.I.D., FAICD, FCPA | Company Secretary |
Profitability and management effectiveness
Profit margin
18.87%
Operating margin
39.50%
Return on assets
6.85%
Return on equity
14.63%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Star Combo Pharma is 32.42M and its enterprise value is 18.43M. The enterprise value to revenue ratio of S66 is 0.66. The enterprise value to EBITDA ratio of S66 is 2.78.
The S66's stocks Beta value is 0.45 making it 55% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Star Combo Pharma (S66)
Star Combo Pharma (ASX:S66) Frequently Asked Questions
1. What is Star Combo Pharma's Stock Symbol?
Star Combo Pharma trades on ASX under the ticker symbol "S66".
2. What is Star Combo Pharma's stock price today?
One share of S66 stock can currently be purchased for approximately $0.24.
3. How can I contact Star Combo Pharma?
Star Combo Pharma's mailing address is 171-177 Woodpark Road Smithfield NSW 2164 Australia. The company can be reached via phone at 61 2 9756 6555.
4. What is Star Combo Pharma's official website?
The official website of Star Combo Pharma is https://www.starcombo.com.au.